Soung J, King B, Tziotzios C, Rudnicka L, Joly P, Gooderham M, Sinclair R, Wajsbrot D, Tran H, Wolk R. Integrated Safety Analysis of Ritlecitinib in Adolescent Patients with Alopecia Areata from the Randomized, Placebo-Controlled ALLEGRO Phase 2b/3 and Ongoing Open-Label Phase 3 ALLEGRO-LT Studies. J of Skin [Internet]. 2023 Nov. 13 [cited 2024 Jul. 3];7(6):s294. Available from: https://jofskin.org/33014/index.php/skin/article/view/2377